Statistics
Publications
59
Citations
7.2K
H-Index
42
Active since
1983
Jeremy Ryan is an author at Dana-Farber Cancer Institute specializing in oncology, apoptosis, and molecular oncology.
Publications per year
1983–2024
59
59
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 735 citations · Full text
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 629 citations · Full text
Medicine, Oncology, Pharmacology +14
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero, Kristopher A. Sarosiek, Joseph D. DeAngelo et al. · Cell · 2015 · 370 citations
Thanh‐Trang Vo, Jeremy Ryan, Ruben D. Carrasco et al. · Cell · 2012 · 339 citations · Full text
Life Sciences, Hematology, Oncology +14
1–5 of 59